Home
About
Overview
Sharing Data
ORCID
Help
History (1)
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Capsid
Humans
Immune Reconstitution Inflammatory Syndrome
JC Virus
Leukoencephalopathy, Progressive Multifocal
Male
Multiple Sclerosis
Mutation
Natalizumab
authors with profiles
Igor J. Koralnik